Editing Guidelines: Finnish Breast Cancer Association Guideline (Finland)

{{forproviders}} {{forpolicymakers}}
Go back to [[Finland]] page

'''Primary purpose:''' To provide comprehensive, evidence-based recommendations for the diagnosis, treatment, and follow-up care of breast cancer patients to ensure optimal patient outcomes and standardized clinical practices.

'''Sponsor, manager or home institution:''' [[dataOwner::Finnish Breast Cancer Group]].

'''Type of information:''' [[availableVariable::medical procedures]], [[availableVariable::screening]], [[availableVariable::cancer prevalence]], [[availableVariable::risk of cancer]], [[availableVariable::palliative care]]. Provides comprehensive guidelines on breast cancer, covering diagnostic pathways, staging, triple diagnostics, imaging follow-up, hereditary breast cancer, core needle biopsy, multidisciplinary treatment planning, surgical and reconstruction options, radiotherapy, neoadjuvant and adjuvant drug treatments, hormonal therapies, chemotherapy, management of recurrent and metastatic breast cancer, special cases like pregnancy, and follow-up care. [https://1587667.167.directo.fi/@Bin/cf27e2ead7d37f99d64b901f77f93dab/1719942972/application/pdf/199460/Rintasyövän%20valtakunnallinen%20diagnostiikka-%20ja%20hoitosuositus%202024.pdf Click here to learn more].

'''Cancer areas of interest:''' [[hasCancerType::C50: Breast cancer]]. [https://rintasyoparyhma.yhdistysavain.fi/hoitosuositus/ Click here to learn more].

'''Access to information:''' [https://rintasyoparyhma.yhdistysavain.fi/hoitosuositus/ Click here to access].